drugset / Trial / NCT05070702
First in Human Study of CT-1500 in Healthy Participants
RandomizedSequentialQuadruple-blindOther
Summary
This study is a single center, randomized, placebo-controlled, double-blind study of CT-1500 in healthy volunteers. The study will evaluate the safety, tolerability and pharmacokinetics of single ascending doses and multiple ascending doses of orally administered CT-1500 compared to placebo.
Timeline
- Start
- 2021-11-08
- Primary completion
- 2022-07-07
- Completion
- 2022-07-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ST1535 | Small molecule | 5 mg | Oral |
| Subject | ST1535 | Small molecule | 45 mg | Oral |
| Subject | ST1535 | Small molecule | 120 mg | Oral |
Indications
No indication recorded.